800.227.0627

Fluorescent Labeling of Oligonucleotides

Fluorescent Labeling of Oligonucleotides 


By Andrei Laikhter

Fluorescent labeling of antibodies, oligonucleotides, peptides and proteins or fluorescent-dye-labeling of these compounds methods used in many biological or biochemical applications. Optimally labeled fluorescent nucleic acids or oligonucleotides are used for the design and synthesis of molecular probes. Fluorescent labeling of oligonucleotides is very useful method employed in a variety of nucleic acid based applications such as in antisense technology, biochemistry, biology, chemistry, cell biology, DNA sequencing, forensic science, genetic analysis, medicinal chemistry, molecular diagnostics, neuroscience, pharmacology, RT-PCR based molecular detection, and many others. However, the major applications of fluorescent labeling of oligonucleotides or fluorogenic oligonucleotides appear to be sequencing, forensic and genetic analysis.

Fluorophores, fluorescent chemical compounds or molecules that can re-emit light upon light excitation, have been and are used for fluorescent labeling of many biomolecules. Oligonucleotides can be be used as reporter molecules and typically contain covalently linked functional modifications. However, most non-radioactive labels incorporated into nucleotides are not stable during chemical synthesis of oligonucleotides. Therefore, blocked nucleophilic groups such as alkyl-sulfhydral or -amines are incorporated during the oligonucleotide synthesis procedure. These groups can then be used to direct the incorporation of nucleophile-specific labeling reagents. Oligonucleotides labeled in this way have a wide variety of applications. Among them are DNA and RNA probes (1,2), micro-arrays, molecular diagnostic probes, automated sequencing(3), electron microscopy, fluorescence microscopy (4) and hybridization affinity chromatography (5).

Structures and spectral properties of fluorescent dyes

Several groups of chromophores consisting of conjugated unsaturated hydrocarbons and hetero-aromatic molecules have strong fluorescent properties. The most common fluorophores employed in fluorescent assays are derived from fluorescein, rhodamine, coumarin or cyanine type of chromophores which structures are illustrated in figure 1.  

Structures of common fluorophors
Figure 1. Structures of the most common fluorophores. Where X is a linker, R is an oligonucleotide.

 

Each of these molecules has a characteristic absorbance spectrum and a characteristic emission spectrum. The specific wavelength at which one of these molecules will most efficiently absorb energy is called the absorbance peak and the wavelength at which it will most efficiently emit energy is called the emission peak as illustrated in figure 2.  

Absorbance and emmision spectra of a fluorophore

Figure 2.  Characterisitics of the absorbance and emission spectra of a fluorophore.

The difference between absorbance peak and emission peak is known as the Stokes Shift.  Absorbance peak and emission peak wavelengths for most of the fluorophores used in molecular applications are shown in Table 1 (for a complete list of the fluorescent dyes please visit our website (6).

Table 1. Fluorescent properties of commonly used dyes.

Dye

Ab (nm)

Em (nm)

SS (nm)

e (M-1cm-1)

Acridine

362

462

100

11,000

Alexa 350

346

442

96

19,000

Alexa 488

495

519

24

71,000

Alexa 594

590

716

26

73,000

Alexa 610

612

628

16

144,000

Alexa 633

632

647

15

159,000

Alexa 700

696

719

23

196,000

AMCA

353

442

89

19,000

ATTO 390

390

479

89

24,000

ATTO 425

436

486

50

45,000

ATTO 465

453

508

55

75,000

ATTO 488

501

523

22

90,000

ATTO 495

495

527

32

80,000

ATTO 590

594

624

30

120,000

ATTO 610

615

634

19

150,000

ATTO 633

629

657

28

130,000

ATTO 647

645

669

24

120,000

ATTO 700

700

719

19

120,000

BODIPY FL

531

545

14

75,000

BODIPY TMR

544

570

26

56,000

BODIPY TR

588

616

28

68,000

Cascade Blue

396

410

14

29,000

Cy2

489

506

17

150,000

Cy3

552

570

18

150,000

Cy3.5

581

596

15

150,000

Cy5

643

667

24

250,000

Cy5.5

675

694

19

250,000

Cy7

743

767 

24

250,000

Edans

335

493

158

5,900

Eosin

521

544

23

95,000

Erythrosin

529

553

24

90,000

6-FAM

494

518

24

83,000

6-TET

521

536

15

-

6-HEX

535

556

21

-

JOE

520

548

28

71,000

LightCycler 640

625

640

15

110,000

LightCycler 705

685

705

20

-

Lissamine

558

583

25

88,000

NBD

465

535

70

22,000

Rhodamine 6G

524

550

26

102,000

Rhodamine Green

504

532

28

78,000

Rhodamine Red

560

580

20

129,000

TAMRA

565

580

15

91,000

ROX

585

605

20

82,000

Texas Red

595

615

20

80,000

NED

546

575

29

-

VIC

538

554

26

-

 
The conjugation or addition of electron withdrawing groups (EWG) to a basic fluorophore moiety usually leads to a red shift resulting in a shift of the absorbance and emission peaks to longer wavelengths or lower energies.      

Methods of incorporation

The most common and convenient method for the attachment of a fluorescent dye to an oligonucleotide is the phosphoramidite method. This method makes it possible to use commercially available fluorescent phosphoramidites for the conjugation or incorporation of one or more fluorophores into or to both, the 5' and/or 3' end, of the oligonucleotide. However, if the fluorophore is not stable in basic conditions needed for the oligonucleotide base deprotection step, the attachment to an oligonucleotide has to be done using a post-synthetic method after the base deprotection step is completed. In this situation, it is best that the oligonucleotide contains a functional group that will react with a reactive moiety on the selected fluorophore resulting in a stable covalent bond between the fluorophore and the oligonucleotide.

Several chemo-selective methods are available that can be used for the post-synthetic oligonucleotide labeling. One of the commonly chemo-selective labeling method used employs amino modified oligonucleotides together with the corresponding NHS esters or similar amine reactive synthons as illustrated in figure 3.

Oligo Labeling with TAMRA NHS EsterFigure 3.  Oligonucleotide labeling using TAMRA NHS ester.


More recently “click chemistry” was successfully employed to label oligonucleotides with various fluorescent reporter molecules (7-9).  This chemical process is outlined in figure 4.

Huisgen 1 3 dipolar cycloaddition

Figure 4.  Huisgen’s 1,3-dipolar cycloaddition between an alkyne modified oligonucleotide (1) and an azide modified reporter molecule (2).  Where R1 and R2 are a hydrogen atom (H) or an extension of the oligonucleotide chain, X is a linker, and Y is a reporter molecule.

The advantage of this chemistry is that it is completely orthogonal to any other attachment method. This chemistry can also be used in addition to any type of Michael-Addition reaction or chemistry as well as any other active esters that are reactive towards alkylamino modified oligonucleotides.

Polymerase dependent polynucleotide labeling using fluorescently labeled deoxynucleoside-5’-triphosphates (NTP) can be considered to be the major method for cDNA labeling (10). This method uses DNA polymerase or terminal deoxynucleotidyl transferase in order to incorporate fluorescently labeled nucleobases with the help of the corresponding NTPs into polynucleotides. These types of oligonucleotides may be used further in any type of micro-array applications.

Dark quenchers suitable for ultrasensitive probes

In recent years Dabcyl, TAMRA and other fluorescent acceptor molecules used in qPCR probes, have been replaced with one or more of the growing family of dark quencher molecules. For this reason, fluorophore-quencher dual-labeled probes have become a standard in kinetic qPCR assay. The properties of dark quencher dyes are provided in table 2.

Table 2.  Characteristic properties of quencher dyes.

Quencher

lmax, nm

e, M-1cm-1

Dabcyl

470

32,000

BHQ2

578

38,000

IB FQ

531

38,000

IQ4

585

59,000


However, even the most efficient quencher dyes show a narrow and limited range of quenching that is predetermined by their narrow absorbance spectra. Therefore, each of the quencher dyes requires a fluorophore within a certain fluorescence emission spectrum range in order to have an efficient energy transfer between the two dyes or chromophors. The broad absorbance spectrum of our new generation of quencher dyes, for Instant for the Quencher dyes (IQ4), makes these probes suitable for multiplexing (11). Their highly efficient quenching characteristics lead to a higher sensitivity expressed by the probe. These significantly improved novel quencher dyes, also showing improved Ct values, now allow for the design of new linear highly sensitive probes. A comparison of the UV spectral properties for standard mono-labeled oligonucleotides are illustrated in the figure 4.  

UV spectra of labeled oligo decamers

Figure 4.  UV Spectra of standard mono-labeled decamer oligonucleotides labeled with the leading quencher dyes.


Biosynthesis, Inc.  now offers all types of fluorescently labeled oligonucleotides including their conjugates with peptides proteins and various nanoparticles. 


References:

  1. Zimmerman, J.; Voss, H.; Schwanger, C.; Stegemann, J.; Erfle, H.; Stucky, K.; Kristensen, T.; Ansorge, W., Nucleic Acids Res., 1990, 18,  1067.
  2. Agrawal, S.; Zamecnik, P. C.,. Nucleic Acids Res., 1990, 18, 5419.
  3. a) Landgraf, A.; Reckmann, B.; Pingoud, A., Anal. Biochem., 1991, 193, 231. b) Lee, L. G.; Connell, C. R. and Bloch, W. Nucleic Acids Res., 1993, 21, 3761. c) Tyagi, S.; Kramer, F. R., Nature Biotechnology, 1996, 14, 303.
  4. Fisher, T. L.; Terhorst, T.; Cao, X.; Wagner, R. W., Nucleic Acids Res., 1993, 21,  3857.
  5. Urdea, M. S.; Warner, B. D.; Running, J. A.; Stempien, M.; Clyne, J.; Horn, T., Nucleic Acids Res., 1988, 16,  4937.
  6. http://www.biosyn.com/oligonucleotide-modification-services.aspx
  7. A.V. Ustinov, et al, Tetrahedron, 2007, 64, 1467-1473.
  8. Agnew, B. et al., US Patent application 20080050731/A1.
  9. X. Ming, P. Leonard, D. Heindle and F. Seela, Nucleic Acid Symposium Series No. 52, 471-472, 2008.
  10. a) Hessner, M.J., X. Wang, K. Hulse, L. Meyer, Y. Wu, S. Nye, S.W. Guo, and S. Ghosh. 2003. Nucleic Acids Res., 2003, 31:e14.  b) C. E. Guerra, BioTechniques, 2006, 41 (1), 53–56.
  11. Laikhter A. et al. US patent 7,956,169.

-.-